Paper Details

  1. Home
  2. Paper Details

Telmisartan 80 mg/hydrochlorothiazide 25 mg single-pill combination in the treatment of hypertension.

Author: RuilopeL M, SchumacherHelmut

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Overview

International guidelines emphasize the importance of blood pressure control to reduce cardiovascular risk. Telmisartan, an angiotensin II receptor blocker, provides large BP reductions and also prevents cardiovascular events in patients at high risk. The thiazide diuretic, hydrochlorothiazide (HCTZ), has a complementary mode of action, and combination with telmisartan is an established and rational treatment option for patients uncontrolled on monotherapy.
Paper Details　
Original Abstract of the Article :
International guidelines emphasize the importance of blood pressure (BP) control to reduce cardiovascular risk. Telmisartan, an angiotensin II receptor blocker, provides large BP reductions and also prevents cardiovascular events in patients at high risk. The thiazide diuretic, hydrochlorothiazide (...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1517/14656566.2012.733698

データ提供：米国国立医学図書館（NLM）

Telmisartan/Hydrochlorothiazide: A Single-Pill Combination for Hypertension

Hypertension, or high blood pressure, is a significant health concern that increases the risk of cardiovascular disease. Telmisartan, an angiotensin II receptor blocker, effectively lowers blood pressure and reduces cardiovascular events in high-risk patients. This study examines the effectiveness of a single-pill combination (SPC) of telmisartan 80 mg and hydrochlorothiazide (HCTZ) 25 mg (T80/H25) in managing hypertension.

A Rational Approach for Blood Pressure Control

This study emphasizes the importance of blood pressure control for reducing cardiovascular risk. The single-pill combination of telmisartan and HCTZ is a rational and convenient treatment option for patients who are not adequately controlled on monotherapy.

Managing Blood Pressure: A Collaborative Effort

This study underscores the importance of a collaborative approach to managing hypertension. By combining the complementary actions of telmisartan and HCTZ in a single pill, individuals can effectively manage their blood pressure, ultimately reducing their risk of cardiovascular complications.

Dr. Camel's Conclusion

Just as a camel relies on its powerful legs to traverse the desert, this study explores the strength of a combined approach to managing hypertension. The single-pill combination of telmisartan and hydrochlorothiazide provides a reliable solution for navigating the complex landscape of blood pressure control.

Date :
  1. Date Completed 2013-03-05
  2. Date Revised 2018-12-02
Further Info :

Pubmed ID

23051558

DOI: Digital Object Identifier

10.1517/14656566.2012.733698

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.